Monday, 25 September, 2023

Big Pharma Harnesses AI to Expedite Clinical Trials

Major pharmaceutical companies are increasingly investing in artificial intelligence (AI) to streamline and accelerate the clinical trial process. AI-powered solutions are being used to analyze vast amounts of patient data, identify potential candidates, and predict trial outcomes. It discusses how these AI-driven approaches hold the potential to revolutionize drug development, making it faster and more efficient while ultimately benefiting patients and the pharmaceutical industry.